New drug applications sought.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D017291:Clarithromycin / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000517:prevention & control; D017277:Drug Approval; D004343:Drug Implants; D004348:Drug Labeling; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006561:Herpes Simplex / Q000150:complications / Q000517:prevention & control; D007262:Infusions, Intravenous; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000517:prevention & control; D018119:Stavudine / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D004343:Drug Implants; D017245:Foscarnet; D018119:Stavudine; D017291:Clarithromycin; D015774:Ganciclovir